Malaria Parasite Density as a Predictor of Hematological Parameter Changes among HIV Infected Adults Attending Two Antiretroviral Treatment Clinics in Kano, Northwest Nigeria

Table 2

Clinical information of HIV-infected participants attending two selected ART clinics in Kano from June 2015 to May 2016 (n = 1521).

Variables	Number (%)
ART status
ART	1288 (84.7)
Non-ART	233 (15.3)
ART start year
2005	54 (3.6)
2006	34 (2.2)
2007	130 (8.5)
2008	156 (10.3)
2009	155 (10.2)
2010	112 (7.4)
2011	82 (5.4)
2012	106 (7.0)
2013	165 (10.8)
2014	178 (11.7)
2015	349 (23.0)
ART regimen (n = 1288)
TDF/3TC/EFV	529 (41.1)
AZT/3TC/NVP	746 (57.9)
Others	13 (1.0)
Current WHO stage
Stage I	348 (22.9)
Stage II	680 (44.7)
Stage II	313 (20.6)
Stage IV	180 (11.8)
Daily dose of cotrimoxazole
No	749 (49.2)
Yes	772 (50.8)

ART: antiretroviral therapy; AZT: zidovudine; EFV: efavirenz; NVP: nevirapine; 3TC: lamivudine; WHO: World Health Organization.